Professor William M. Gallagher

Professor William M. Gallagher

University College Dublin

H-index: 74

Europe-Ireland

About Professor William M. Gallagher

Professor William M. Gallagher, With an exceptional h-index of 74 and a recent h-index of 49 (since 2020), a distinguished researcher at University College Dublin, specializes in the field of Cancer biology, therapeutics, personalised medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Method of predicting risk of recurrence of cancer

Abstract B019: Investigating Cannabis sativa bioactive compounds as an anti-cancer treatment in high-grade serous ovarian cancer

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer

IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance

A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring

Abstract PS16-10: SPATIAL IMMUNE CELL DISTRIBUTION CAN REFINE PROGNOSIS IN EARLY-STAGE ER+/HER2-/LN-BREAST CANCER

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

Professor William M. Gallagher Information

University

Position

UCD Conway Institute

Citations(all)

24708

Citations(since 2020)

9931

Cited By

18776

hIndex(all)

74

hIndex(since 2020)

49

i10Index(all)

215

i10Index(since 2020)

158

Email

University Profile Page

University College Dublin

Google Scholar

View Google Scholar Profile

Professor William M. Gallagher Skills & Research Interests

Cancer biology

therapeutics

personalised medicine

Top articles of Professor William M. Gallagher

Title

Journal

Author(s)

Publication Date

Method of predicting risk of recurrence of cancer

2024/1/4

Abstract B019: Investigating Cannabis sativa bioactive compounds as an anti-cancer treatment in high-grade serous ovarian cancer

Cancer Research

Claire Hughes

Rianna Magee

William Gallagher

Susanne Schilling

Antoinette Perry

2024/3/4

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

The Lancet Child & Adolescent Health

Saul N Faust

Richard Haynes

Christine E Jones

Natalie Staplin

Elizabeth Whittaker

...

2024/3/1

Deciphering epigenetic regulation of enhancers in high‐risk prostate cancer

Genes, Chromosomes and Cancer

AV Tuzova

B Moran

NM Russell

S Das

F Delahaye

...

2024/2

IMPROVER (Involving Men with Prostate Cancer in Engaged Research): Assessing Patient Experience With Testing, Diagnosis, And Surveillance

Clinical Genitourinary Cancer

Marc Walsh

Asia Jordan

Lea Schäfer

Jana Joha

Ben Heapes

...

2024/6/1

A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring

Scientific Reports

Kate Connor

Emer Conroy

Kieron White

Liam P Shiels

Simon Keek

...

2024/2/1

Abstract PS16-10: SPATIAL IMMUNE CELL DISTRIBUTION CAN REFINE PROGNOSIS IN EARLY-STAGE ER+/HER2-/LN-BREAST CANCER

Cancer Research

Zak Kinsella

Hannah Nyarko

Anna Blümel

Mairi Lucas

Daria Kalinska-Lysiak

...

2024/5/2

Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer

Chowdhury Arif Jahangir

David B Page

Glenn Broeckx

Claudia A Gonzalez

Caoimbhe Burke

...

2024/1/17

Abstract PO3-18-08: Rational therapeutic combination of Bromodomain and Extra-Terminal domain (BET) inhibitor and Fibroblast Growth Factor Receptor (FGFR) inhibitor for …

Cancer Research

Binbin Gao

Elspeth Ward

Anna Blümel

Emer Conroy

Rachel Moore

...

2024/5/2

Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells

Journal of Natural Products

Eve O’Reilly

Karima Khalifa

Joanne Cosgrave

Haleema Azam

Maria Prencipe

...

2023/9/13

78P Multiplex immunohistochemistry and digital pathology analysis examining the prevalence and prognostic value of tertiary lymphoid structures in early stage hormone positive …

ESMO Open

MW Lucas

C Hurley

Z Kinsella

C Gonzalez

C Burke

...

2023/5/1

SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer

Cell Cycle

Haleema Azam

Shane Maher

Shane Clarke

William M Gallagher

Maria Prencipe

2023/8/18

Health diplomacy in action: the cancer legacy of the Good Friday Agreement

Journal of Cancer Policy

Mark Lawler

Richard Sullivan

Ghassan K Abou-Alfa

Karen McCloskey

Debbie Keatley

...

2023/12/1

Modelling the spatial heterogeneity of CD45-positive tumor infiltrating lymphocytes in early-stage, estrogen receptor-positive breast cancer

Cancer Research

Zak Kinsella

Anna Blümel

Mairi Lucas

Andreas Lindner

Claudia A Gonzalez

...

2023/4/4

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast …

David B Page

Glenn Broeckx

Chowdhury Arif Jahangir

Sara Verbandt

Rajarsi R Gupta

...

2023/8

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Diabetes & Endocrinology

O Abani

A Abbas

F Abbas

J Abbas

K Abbas

...

2023/12/1

MP17-08 CLINICAL VALIDATION OF A NOVEL SIX-GENE RISK-STRATIFICATION SIGNATURE TO SUPPORT TREATMENT DECISIONS FOR MEN DIAGNOSED WITH PROSTATE CANCER

The Journal of Urology

Agnieszka Krzyzanowska

Stephen Barron

Debra F Higgins

Tony Loughman

Katherine M Sheehan

...

2023/4

Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on …

Jeppe Thagaard

Glenn Broeckx

David B Page

Chowdhury Arif Jahangir

Sara Verbandt

...

2023/8

Local anaesthesia transperineal (LATP) biopsy of the prostate: a new era for prostate cancer diagnosis?

European Urology Open Science

P Lim

J Low

E Hurton

W Gallagher

P Rajjayabun

2023/11/1

Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.

Agnieszka Krzyzanowska

Stephen Barron

Debra Higgins

Tony Loughman

Katherine Sheehan

...

2023/2/20

See List of Professors in Professor William M. Gallagher University(University College Dublin)